Our projects

Over the last decade, the treatment of immunological diseases has improved dramatically. However, current drugs have several shortcomings, such as adverse side effects, administration forms that often require visits to the hospital and poor response or resistance in some patients. Cyxone is addressing the need for efficacious, tolerable and convenient drugs against autoimmune disease that can modify or prevent disease progression at an early stage.

Project Status

Phase 1
Phase 2
Phase 3

Our Drug Projects

Rheumatoid Arthritis (rabeximod)

A unique mechanism-of-action combined with a convenient oral administration and a beneficial tolerability profile

Read More

Multiple sclerosis (T20K)

Acts to stop or slow down the progression of multiple sclerosis

Read More